Itk inhibitors: a patent review
- 11 March 2010
- journal article
- review article
- Published by Informa Healthcare in Expert Opinion on Therapeutic Patents
- Vol. 20 (4), 459-469
- https://doi.org/10.1517/13543771003674409
Abstract
(2010). Itk inhibitors: a patent review. Expert Opinion on Therapeutic Patents: Vol. 20, No. 4, pp. 459-469. doi: 10.1517/13543771003674409Keywords
This publication has 29 references indexed in Scilit:
- Inhibitors of the tyrosine kinase signaling cascade for asthmaCurrent Opinion in Pharmacology, 2005
- Interleukin-2–Inducible T Cell Kinase Regulates Mast Cell Degranulation and Acute Allergic ResponsesAmerican Journal of Respiratory Cell and Molecular Biology, 2005
- Attenuation of Immunological Symptoms of Allergic Asthma in Mice Lacking the Tyrosine Kinase ITKThe Journal of Immunology, 2003
- Altering T-cell activation by targeting the multidomain tyrosine kinase ItkTrends in Immunology, 2003
- Signal Transduction Mediated by the T Cell Antigen Receptor: The Role of Adapter ProteinsAnnual Review of Immunology, 2002
- Mutation of Tec family kinases alters T helper cell differentiationNature Immunology, 2001
- The Tec family of cytoplasmic tyrosine kinases: mammalian Btk, Bmx, Itk, Tec, Txk and homologs in other speciesBioEssays, 2001
- Impaired NFATc Translocation and Failure of Th2 Development in Itk-Deficient CD4+ T CellsImmunity, 1999
- Requirement for Tec Kinases Rlk and Itk in T Cell Receptor Signaling and ImmunityScience, 1999
- T cell antigen receptor signal transductionCurrent Opinion in Cell Biology, 1997